Clinical Performance of Two HEMA-Free Universal Adhesive Systems
NCT: NCT07731061 · NOT_YET_RECRUITING
Brief Summary
This randomized controlled clinical trial aims to compare the 12-month clinical performance of two HEMA-free universal adhesive systems for restoring anterior cervical carious lesions. Participants will be randomly allocated (1:1) to receive restorations using either a two-bottle HEMA-free universal adhesive (G2-Bond Universal) or a one-bottle HEMA-free universal adhesive (BeautiBond Xtreme), both applied in self-etch mode. The primary outcome is restoration retention, while secondary outcomes include marginal adaptation, marginal discoloration, and postoperative sensitivity, evaluated at baseline (24 hours), 6 months, and 12 months using the modified USPHS criteria.
Frequently Asked Questions
What is Clinical Performance of Two HEMA-Free Universal Adhesive Systems?
Clinical Performance of Two HEMA-Free Universal Adhesive Systems is a clinical trial registered under NCT07731061. Current status: NOT_YET_RECRUITING.
What is the status of NCT07731061?
The current status of NCT07731061 (Clinical Performance of Two HEMA-Free Universal Adhesive Systems) is: NOT_YET_RECRUITING.
When did Clinical Performance of Two HEMA-Free Universal Adhesive Systems start?
Clinical Performance of Two HEMA-Free Universal Adhesive Systems started on 2026-11.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.